Adrian Schreiber
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Rapid and profound treatment response of difficult-to-treat rheumatoid arthritis to CD19 CAR T-cell therapy.
Journal: EULAR rheumatology open
Published: August 01, 2026
Trial End Points in Anti-neutrophil Cytoplasmic Antibody‑Associated Vasculitis: Are We Missing the Boat?
Journal: Journal of the American Society of Nephrology : JASN
Published: July 13, 2026
2,3-Bisphosphoglycerate Mutase (BPGM), a Metabolic Player Shaping Stress-Adaptive Transcriptional States in Clear Cell Renal Cell Carcinoma.
Journal: Cells
Published: February 23, 2026
Vasculitides and anti-GBM disease
Journal: Innere Medizin (Heidelberg, Germany)
Published: December 18, 2025
Towards a proteomic plasma biomarker panel for diagnosing vasculitis remission.
Journal: Nature communications
Published: September 16, 2025
CAR-T cells targeting CD19 for the treatment of ANCA vasculitis.
Journal: Clinical kidney journal
Published: July 28, 2025
CRISPR-Cas9 mediated proteinase 3 autoantigen deletion as a treatment strategy for anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
Journal: Kidney international
Published: February 25, 2025
Anti-CD19 CAR T cell therapy induces antibody seroconversion and complete B cell depletion in the bone marrow of a therapy-refractory patient with ANCA-associated vasculitis.
Journal: Annals of the rheumatic diseases
Published: September 17, 2024
Highlights from the plenary session: cellular and molecular mechanisms of disease (I).
Journal: Rheumatology (Oxford, England)
Published: July 22, 2024
Flow-Cytometric Quantification of Urine Kidney Epithelial Cells Specifically Reflects Tubular Damage in Acute Kidney Diseases.
Journal: Kidney international reports
Published: July 03, 2024
Last Updated: 09/26/2026